Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study

Bart A. Mulder, Dirk J. Van Veldhuisen, Harry J. G. M. Crijns, Jan G. P. Tijssen, Hans L. Hillege, Marco Alings, Michiel Rienstra, Maarten P. Van den Berg, Isabelle C. Van Gelder

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1543-1550
JournalHeart Rhythm
Volume11
Issue number9
DOIs
Publication statusPublished - Sep 2014

Keywords

  • Atrial fibrillation
  • Digoxin
  • Morbidity
  • Mortality
  • Rate control

Cite this

Mulder, B. A., Van Veldhuisen, D. J., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Rienstra, M., Van den Berg, M. P., & Van Gelder, I. C. (2014). Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study. Heart Rhythm, 11(9), 1543-1550. https://doi.org/10.1016/j.hrthm.2014.06.007